Projected Income Statement: Procter & Gamble Company

Forecast Balance Sheet: Procter & Gamble Company

Forecast Balance Sheet - Procter & Gamble Company
Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
Net Debt 1 24,279 26,361 22,978 24,952 24,196 24,402 23,285 21,525
Change - 8.58% -12.83% 8.59% -3.03% 0.85% -4.58% -7.56%
Announcement Date 7/29/22 A 7/28/23 A 7/30/24 A 7/29/25 A 7/29/26 A - - -
1USD in Million
Estimates

Cash Flow Forecast: Procter & Gamble Company

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029
CAPEX 1 3,156 3,062 3,322 3,773 4,409 4,424 4,249 4,315
Change - -2.98% 8.49% 13.58% 16.86% 0.33% -3.94% 1.55%
Free Cash Flow (FCF) 1 13,567 13,786 16,524 14,606 15,147 15,490 16,395 17,398
Change - 1.61% 19.86% -11.61% 3.7% 2.27% 5.84% 6.11%
Announcement Date 7/29/22 A 7/28/23 A 7/30/24 A 7/29/25 A 7/29/26 A - - -
1USD in Million
Estimates

Forecast Financial Ratios: Procter & Gamble Company

Fiscal Period: June 2022 2023 2024 2025 2026 2027 2028 2029

Profitability

        
EBITDA Margin (%) 25.71% 25.42% 27.23% 27.65% 27.18% 27.29% 27.9% 28.29%
EBIT Margin (%) 22.21% 22.11% 23.78% 24.27% 23.55% 23.57% 24.03% 24.39%
EBT Margin (%) 22.44% 22.38% 22.32% 23.93% 23.41% 23.19% 24.06% 24.24%
Net margin (%) 18.38% 17.87% 17.7% 18.95% 18.44% 18.5% 19.2% 19.4%
FCF margin (%) 16.92% 16.81% 19.66% 17.33% 17.4% 17.43% 17.91% 18.41%
FCF / Net Income (%) 92.03% 94.08% 111.06% 91.44% 94.4% 94.23% 93.26% 94.92%

Profitability

        
ROA 12.47% 12.31% 13.39% 12.9% 12.75% 12.97% 13.39% 13.58%
ROE 31.53% 31.2% 30.48% 31.06% 30.11% 30.52% 31.73% 32.24%

Financial Health

        
Leverage (Debt/EBITDA) 1.18x 1.26x 1x 1.07x 1.02x 1.01x 0.91x 0.81x
Debt / Free cash flow 1.79x 1.91x 1.39x 1.71x 1.6x 1.58x 1.42x 1.24x

Capital Intensity

        
CAPEX / Current Assets (%) 3.94% 3.73% 3.95% 4.48% 5.07% 4.98% 4.64% 4.57%
CAPEX / EBITDA (%) 15.31% 14.69% 14.52% 16.19% 18.64% 18.24% 16.64% 16.14%
CAPEX / FCF (%) 23.26% 22.21% 20.1% 25.83% 29.11% 28.56% 25.92% 24.8%

Items per share

        
Cash flow per share 1 6.586 6.783 8.029 7.259 8.073 8.164 9.083 9.524
Change - 2.99% 18.37% -9.58% 11.21% 1.13% 11.25% 4.87%
Dividend per Share 1 3.523 3.681 3.829 4.076 4.259 4.396 4.592 4.805
Change - 4.47% 4.02% 6.47% 4.48% 3.23% 4.46% 4.64%
Book Value Per Share 1 19.57 19.8 20.45 21.3 22.42 23.64 24.61 25.8
Change - 1.18% 3.28% 4.15% 5.24% 5.46% 4.08% 4.85%
EPS 1 5.81 5.9 6.02 6.51 6.62 6.804 7.374 7.754
Change - 1.55% 2.03% 8.14% 1.69% 2.78% 8.37% 5.16%
Nbr of stocks (in thousands) 2,399,297 2,356,969 2,360,135 2,344,542 2,328,599 2,322,672 2,322,672 2,322,672
Announcement Date 7/29/22 A 7/28/23 A 7/30/24 A 7/29/25 A 7/29/26 A - - -
1USD
Estimates
2027 *2028 *
P/E 23.4x 21.6x
PBR 6.74x 6.48x
EV / Sales 4.44x 4.3x
Yield 2.76% 2.88%

EPS & Dividend

EPS & Dividend - Procter & Gamble Company


Y-o-Y evolution of P/E

Valuation ratios - P/E - Procter & Gamble Company
 

Year-on-year evolution of the Yield

Valuation ratios - Yield - Procter & Gamble Company
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Procter & Gamble Company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
159.35USD
Average target price
161.65USD
Spread / Average Target
+1.44%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Procter & Gamble Company
  1. Stock Market
  2. Stocks
  3. PG Stock
  4. Financials Procter & Gamble Company